PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, University of Toronto, Toronto, Ontario, Canada.\', \'Mood Disorders Psychopharmacology Unit, Poul Hansen Family Centre for Depression, University Health Network, Toronto, Ontario, Canada.\', \'Braxia Health, Mississauga, Ontario, Canada.\', \'Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.\', \'Department of Affective Disorders, the Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China.\', \'Laboratory of Emotion and Cognition, the Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China.\', \'Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.\', \'Institute for Health Innovation and Technology, National University of Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jamapsychiatry.2021.1818
?:doi
?:hasPublicationType
?:journal
  • JAMA psychiatry
is ?:pmid of
?:pmid
?:pmid
  • 34319365
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.097
?:rankingScore_hIndex
  • 327
is ?:relation_isRelatedTo_publication of
?:title
  • Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all